Risk assessmentindependent cross-checkabstract checked I-UPF-121 standard review

EU safety review of cellulose additives (including CMC)

Re-evaluation of celluloses E 460(i), E 460(ii), E 461, E 462, E 463, E 464, E 465, E 466, E 468 and E 469 as food additives.

Overview

EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) et al.. EFSA J 2018 · PMID 32625652 · DOI 10.2903/j.efsa.2018.5047

EFSA found no safety concern for cellulose additives such as carboxymethylcellulose at the levels used in food.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

To re-evaluate cellulose food additives.

How was the study done?

Regulatory risk assessment.

How many people, animals or samples were studied?

Not applicable.

What was actually found?

No toxicity concerns at reported uses.

How large was the observed effect?

Not applicable.

What do the results mean in everyday life?

Authorities consider CMC safe at current levels.

What are the study's limitations?

Mainly animal toxicology; microbiome data not decisive.

What does it say about Elawady's specific claim?

Contradicts C-UPF-06.

Do the results apply to Germany and Europe?

EU.

What can explicitly not be concluded from this study?

Cannot exclude subtle gut effects.

Scientific in-depth review

1. Full reference

Authors
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) et al.
Journal
EFSA J
Year
2018
Identifier
PMID 32625652 DOI 10.2903/j.efsa.2018.5047 · PMC7009359
Verification
verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

EFSA panel opinion (declarations of interest managed by EFSA; not reviewed here)

2. Research question

Are unmodified and modified celluloses (including sodium carboxymethylcellulose E 466) safe at reported uses?

3. Study design and population

Study design
Risk assessment – EFSA scientific opinion (re-evaluation of celluloses E 460-E 469 as food additives)
Population

General population (exposure assessment)

Country

EU

Period

2018

Sample size

Not applicable

Inclusion and exclusion criteria

Toxicological and exposure data

4. Methods and endpoints

Exposure / intervention

Celluloses E 460-466, E 468, E 469

Comparator

Not applicable

Endpoints

Toxicity endpoints; exposure

Statistical methods

Risk assessment

5. Actual results

Results

Celluloses not absorbed and excreted intact; can be fermented by gut flora. Low acute toxicity; no genotoxic concern; no adverse effects in subchronic studies up to 10% of diet; chronic NOAELs up to 9,000 mg/kg bw/day; no carcinogenicity; no reproductive/developmental effects above 1,000 mg/kg bw. 95th percentile exposure up to 506 mg/kg bw/day. No numerical ADI needed; no safety concern at reported uses and use levels.

Absolute risks

Not applicable

Authors' conclusion

No need for a numerical ADI; no safety concern at reported uses and use levels for celluloses including E 466.

6. Strengths

  • Comprehensive regulatory review

7. Weaknesses

  • Did not weigh microbiome/mucus findings from Chassaing 2015 as adverse endpoints (not stated in abstract)
  • Animal toxicology endpoints

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Regulatory risk assessment.

9. Assessment of the statistical interpretation

Not applicable.

10. Relevance to the specific claim

The responsible EU regulator found no safety concern for CMC at reported uses; contrasts with the claim.

11. Independent contrary findings

Microbiome-based concerns (A-UPF-15, A-UPF-16).

12. Transferability to Germany and Europe

Directly applicable (EU).

13. Overall methodological judgement

Regulatory reassurance; does not settle microbiome questions.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biasnot assessable
Precision of resultsnot applicable
Directnessindirect
Reproducibilityreplicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Whether future re-evaluations consider microbiome data.

15. Linked fact checks